Trial intelligence / Profile preview

Losartan for Endothelial Dysfunction and Insulin Resistance in Obese Patients

NCT00675987Phase 4Completed

Sponsor
Brigham and Women's Hospital
Start
May 2007
Primary completion
Dec 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of losartan in hypertension (HTN), impaired fasting glucose (IFG), sponsored by Brigham and Women's Hospital. Started May 2007; status: completed.

02

Drugs

losartan
03

Conditions

hypertension (HTN)impaired fasting glucose (IFG)

Beyond the preview

Go deeper on NCT00675987.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00675987.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call